April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Endothelin B (ETB) Receptors Contribute to Neurodegeneration in a Rodent Model of Glaucoma via Upregulation of c-Jun and Bax
Author Affiliations & Notes
  • Alena Z Minton
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Institute, Fort Worth, TX
  • Shaoqing He
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Institute, Fort Worth, TX
  • Hai-Ying Ma
    Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX
  • Raghu R Krishnamoorthy
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Institute, Fort Worth, TX
  • Footnotes
    Commercial Relationships Alena Minton, None; Shaoqing He, None; Hai-Ying Ma, None; Raghu Krishnamoorthy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1900. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alena Z Minton, Shaoqing He, Hai-Ying Ma, Raghu R Krishnamoorthy; Endothelin B (ETB) Receptors Contribute to Neurodegeneration in a Rodent Model of Glaucoma via Upregulation of c-Jun and Bax. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1900.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Previously, our lab has demonstrated that increased levels of ETB receptors contribute to the death of retinal ganglion cells (RGCs) and degeneration of optic nerve axons in the Morrison's elevated intraocular pressure (IOP) model of glaucoma in rats. Moreover, these pathological changes were greatly attenuated in ETB receptor-deficient transgenic Wistar Kyoto rats. Interestingly, an increase in ETB receptor levels in RGCs, following 2 weeks of IOP elevation in Brown Norway rats, was shown to be associated with increased expression of c-Jun, a member of the activator protein-1 (AP-1) family. The current study was aimed at investigating whether the increased expression of c-Jun observed in wild type rats is reduced in ETB receptor-deficient Wistar Kyoto rats subjected to the Morrison’s model of glaucoma. The status of another apoptotic protein, Bax, was also assessed in these rats.

Methods: IOP was elevated in one eye of adult wild type and ETB receptor-deficient transgenic Wistar Kyoto rats using the Morrison’s method (injection of hypertonic saline through episcleral veins), while the contralateral eye served as control. After IOP was elevated, rats were maintained for 2 weeks and sacrificed. Retinal sections were obtained and stained with specific antibodies to detect the expression of c-Jun and Bax by immunohistochemistry. In addition, retinal sections were immunostained using an antibody to βIII-tubulin, which is selectively expressed by RGCs in the retina. Images were taken using Zeiss LSM-510 confocal microscope with Z-scan.

Results: Immunohistochemical analysis showed that IOP elevation for 2 weeks caused increased expression of c-Jun and Bax mainly in the ganglion cell layer (GCL) of wild type transgenic Wistar Kyoto rats as compared to ETB receptor-deficient transgenic Wistar Kyoto rats. Interestingly, using the Promo 3 software, we found 15 binding sites for members of the AP-1 family of proteins on the rat 1.95 kb upstream promoter region of Bax. Therefore, the transcription factor c-Jun may be an upstream regulator of Bax (pro-apoptotic factor).

Conclusions: Transcription factor AP-1 could be involved in the elevation of the ETB receptor levels in the Morrison's model of glaucoma. Conversely, deletion of the ETB receptor results in the downregulation of c-Jun. Taken together, there may be a reciprocal feedback loop between the AP-1 and ETB receptors.

Keywords: 426 apoptosis/cell death • 531 ganglion cells • 674 receptors  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×